hsa-mir-4771-2

Display Libraries
(1) AGO1.ip	(1) AGO2.ip	(5) B-CELL	(16) CELL-LINE	(1) FIBROBLAST	(2) HEART	(3) HELA	(1) LIVER	(4) OTHER	(6) SKIN	(1) UTERUS	(1) XRN.ip

CAGCATCCCAGCTCCTCAGGTGAATTAATACATGGCCAAGCCCTAAGCCTGCTCTAGCCTAATTTTAGATCTGGTCTGCTTCAGTTTCACTCCAAGCAGACTTGACCTACAATTAGCCTAGAGCAGAACTAAGGTGATCTGTGTGCTTTCTCCCCACCTGACAGAAGAAAATGT
..................................................((.((((((.(((.((.(((((((((.((.....))..))))))))).)).))).)))))).)).......................................................
.......................................................56..................................................................124................................................

Size

Perfect hit

Total Norm

Perfect Norm

SRR189782

SRR207113(GSM721075)
IP against AGO 1 & 2. (ago1/2 cell line)

SRR207115(GSM721077)
XRN1&2 knockdown. (XRN1/XRN2 cell line)

SRR387909(GSM843861)
specific-host: Homo sapienshost cell line: Su. (cell line)

SRR326279(GSM769509)
cytoplasmic fraction was isolated using PARIS. (cell line)

DRR001489(DRX001043)
Hela short nuclear cell fraction, control. (hela)

SRR326280(GSM769510)
total cell content of unperturbed cells was s. (cell line)

SRR207116(GSM721078)
Nuclear RNA. (cell line)

SRR033722(GSM497067)
KMS12 cell line (KMS12). (B cell)

SRR033724(GSM497069)
L428 cell line (L428). (B cell)

SRR039193(GSM494812)
HL60 cell line is derived from acute promyelo. (cell line)

SRR189786

SRR330880(SRX091718)
tissue: skin psoriatic involveddisease state:. (skin)

SRR037936(GSM510474)
293cand1. (cell line)

SRR207111(GSM721073)
Whole cell RNA. (cell line)

SRR039192(GSM494811)
K562 cell line is derived from a CML patient . (cell line)

SRR094132(GSM651908)
small RNA(18-35nt)small RNA deep sequencing o. (uterus)

SRR342898(SRX096794)
small RNA seq of Right atrial tissue. (heart)

DRR001482(DRX001036)
Hela long total cell fraction, control. (hela)

DRR001488(DRX001042)
Hela short nuclear cell fraction, LNA(+). (hela)

SRR330872(SRX091710)
tissue: skin psoriatic involveddisease state:. (skin)

SRR039616(GSM531979)
HBV(+) Distal Tissue Sample 1. (liver)

SRR189784

SRR060983(GSM569187)
Human pre-germinal center B cell [09-001]. (cell line)

SRR330881(SRX091719)
tissue: skin psoriatic uninvolveddisease stat. (skin)

SRR330864(SRX091702)
tissue: skin psoriatic involveddisease state:. (skin)

SRR189785

SRR387910(GSM843862)
antibody for ip: Ago2. (ago2 cell line)

SRR033727(GSM497072)
HIV-positive DL (HIV412). (B cell)

SRR189779(GSM714639)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)

SRR033713(GSM497058)
Burkitt Lymphoma (BL115). (B cell)

SRR330870(SRX091708)
tissue: skin psoriatic involveddisease state:. (skin)

SRR037934(GSM510472)
293cand4_rep3. (cell line)

SRR033714(GSM497059)
Burkitt Lymphoma (BL134). (B cell)

SRR363673(GSM830250)
cell type: human foreskin fibroblasts (HFF)tr. (fibroblast)

SRR342896(SRX096792)
small RNA seq of Right atrial tissue. (heart)

SRR330916(SRX091754)
tissue: normal skindisease state: normal. (skin)

GSM541797(GSM541797)
differentiated human embryonic stem cells. (cell line)

SRR060981(GSM569185)
Human centroblast [09-001]. (cell line)

............................................................AATTTTAGATCTGGTCTGCTT.............................................................................................

15.00

0.50

3.50

3.00

1.50

2.00

1.00

0.50

...........................................................TAATTTTAGATCTGGTCTGCT..............................................................................................

6.50

4.50

0.50

............................................................AATTTTAGATCTGGTCTGCT..............................................................................................

6.00

1.00

0.50

2.00

0.50

...........................................................TAATTTTAGATCTGGTCTGCTT.............................................................................................

4.50

1.50

0.50

..............................................................................................AGCAGACTTGACCTACAATTAG..........................................................

4.00

2.50

1.00

0.50

...........................................................TAATTTTAGATCTGGTCTG................................................................................................

1.50

0.50

1.00

...........................................................TAATTTTAGATCTGGTCTGCTTa............................................................................................

1.50

4.50

1.00

0.50

..............................................................................................AGCAGACTTGACCTACAATTA...........................................................

1.00

...........................................................TAATTTTAGATCTGGTC..................................................................................................

1.00

............................................................AATTTTAGATCTGGTCTGCTTC............................................................................................

1.00

0.50

.................................................................................................AGACTTGACCTACAATTAG..........................................................

1.00

...........................................................TAATTTTAGATCTGGTCTGC...............................................................................................

1.00

0.50

............................................................AATTTTAGATCTGGTCTGCa..............................................................................................

0.50

............................................................AATTTTAGATCTGGTCTGCTc.............................................................................................

0.50

6.00

0.50

...........................................................TAATTTTAGATCTGGTCTGCTTaa...........................................................................................

0.50

4.50

0.50

.................................................................................................AGACTTGACCTACAATTAGC.........................................................

0.50

....................................................................................TTTCACTCCAAGCAGACTTGACCTAC................................................................

0.50

..............................................................................................AGCAGACTTGACCTACAAatag..........................................................

ATAG

0.50

0.00

0.50

...................................................................................................................................AGGTGATCTGTGTGCaaca........................

AACA

0.50

0.00

0.50

.........................................................CCTAATTTTAGATCTGGTCTGCT..............................................................................................

0.50

...........................................................................CTGCTTCAGTTTCACatt.................................................................................

ATT

0.50

0.00

0.50

............................................................AATTTTAGATCTGGTCTGC...............................................................................................

0.50

...........................................................TAATTTTAGATCTGGTCTGCTaaa...........................................................................................

AAA

0.50

6.50

0.50

..............................................................................................AGCAGACTTGACCTACAActat..........................................................

CTAT

0.50

0.00

0.50

.............................................................ATTTTAGATCTGGTCTGCTT.............................................................................................

0.50

.....................................................................................................................CTAGAGCAGAACTAAGGTGATC...................................

0.50

...........................................................TAATTTTAGATCTGGTCTGCTTtc...........................................................................................

0.50

4.50

0.50

............................................................AATTTTAGATCTGGTCTGCTTt............................................................................................

0.50

15.00

0.50

CAGCATCCCAGCTCCTCAGGTGAATTAATACATGGCCAAGCCCTAAGCCTGCTCTAGCCTAATTTTAGATCTGGTCTGCTTCAGTTTCACTCCAAGCAGACTTGACCTACAATTAGCCTAGAGCAGAACTAAGGTGATCTGTGTGCTTTCTCCCCACCTGACAGAAGAAAATGT ..................................................((.((((((.(((.((.(((((((((.((.....))..))))))))).)).))).)))))).))....................................................... .......................................................56..................................................................124................................................	Size	Perfect hit	Total Norm	SRR189782	SRR207113(GSM721075) IP against AGO 1 & 2. (ago1/2 cell line)	SRR207115(GSM721077) XRN1&2 knockdown. (XRN1/XRN2 cell line)	SRR387909(GSM843861) specific-host: Homo sapienshost cell line: Su. (cell line)	SRR326279(GSM769509) cytoplasmic fraction was isolated using PARIS. (cell line)	DRR001489(DRX001043) Hela short nuclear cell fraction, control. (hela)	SRR326280(GSM769510) total cell content of unperturbed cells was s. (cell line)	SRR207116(GSM721078) Nuclear RNA. (cell line)	SRR033722(GSM497067) KMS12 cell line (KMS12). (B cell)	SRR033724(GSM497069) L428 cell line (L428). (B cell)	SRR039193(GSM494812) HL60 cell line is derived from acute promyelo. (cell line)	SRR189786	SRR330880(SRX091718) tissue: skin psoriatic involveddisease state:. (skin)	SRR037936(GSM510474) 293cand1. (cell line)	SRR207111(GSM721073) Whole cell RNA. (cell line)	SRR039192(GSM494811) K562 cell line is derived from a CML patient . (cell line)	SRR094132(GSM651908) small RNA(18-35nt)small RNA deep sequencing o. (uterus)	SRR342898(SRX096794) small RNA seq of Right atrial tissue. (heart)	DRR001482(DRX001036) Hela long total cell fraction, control. (hela)	DRR001488(DRX001042) Hela short nuclear cell fraction, LNA(+). (hela)	SRR330872(SRX091710) tissue: skin psoriatic involveddisease state:. (skin)	SRR039616(GSM531979) HBV(+) Distal Tissue Sample 1. (liver)	SRR189784	SRR060983(GSM569187) Human pre-germinal center B cell [09-001]. (cell line)	SRR330881(SRX091719) tissue: skin psoriatic uninvolveddisease stat. (skin)	SRR330864(SRX091702) tissue: skin psoriatic involveddisease state:. (skin)	SRR189785	SRR387910(GSM843862) antibody for ip: Ago2. (ago2 cell line)	SRR033727(GSM497072) HIV-positive DL (HIV412). (B cell)	SRR189779(GSM714639) cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)	SRR033713(GSM497058) Burkitt Lymphoma (BL115). (B cell)	SRR330870(SRX091708) tissue: skin psoriatic involveddisease state:. (skin)	SRR037934(GSM510472) 293cand4_rep3. (cell line)	SRR033714(GSM497059) Burkitt Lymphoma (BL134). (B cell)	SRR363673(GSM830250) cell type: human foreskin fibroblasts (HFF)tr. (fibroblast)	SRR342896(SRX096792) small RNA seq of Right atrial tissue. (heart)	SRR330916(SRX091754) tissue: normal skindisease state: normal. (skin)	GSM541797(GSM541797) differentiated human embryonic stem cells. (cell line)	SRR060981(GSM569185) Human centroblast [09-001]. (cell line)
ttagATCCCAGCTCCTCAG...........................................................................................................................................................	19	ttag	0.50	-	-	0.50	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
....ttaCCAGCTCCTCAGGTG........................................................................................................................................................	18	tta	0.50	-	-	0.50	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
........................................................................................................................................................gcttCCTGACAGAAGAAAAT..	20	gctt	0.50	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.50	-	-	-	-	-	-	-	-	-